The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShearwater Regulatory News (SWG)

Share Price Information for Shearwater (SWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.00
Bid: 43.00
Ask: 45.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.651%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 44.00
SWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CH2M HILL announcement re Scott Wilson

28 Jun 2010 07:15

RNS Number : 3179O
CH2M HILL
28 June 2010
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

FOR IMMEDIATE RELEASE

28 June 2010

 

CH2M HILL announcement re Scott Wilson

 

 

CH2M HILL Companies, Ltd ("CH2M HILL") notes today's announcement by URS Corporation of a recommended offer for Scott Wilson Group plc ("Scott Wilson").

 

CH2M HILL has undertaken due diligence on Scott Wilson and is considering its position with respect to making a cash offer for Scott Wilson. CH2M HILL will make a further announcement shortly.

 

This announcement does not constitute an announcement of a firm intention to make an offer under Rule 2.5 of the Takeover Code and there can be no certainty that any offer will ultimately be made by CH2M HILL for Scott Wilson, nor as to the terms and conditions on which any might be made.

 

Contacts:

 

CH2M HILL Jacqueline Rast +44 (0) 207 404 5959

 

Rothschild: Paul Simpson +44 (0)121 600 5252

(financial adviser) Stuart Vincent +44 (0) 207 280 5436

 

Investec: Keith Anderson +44 (0) 207 597 5110 (corporate broker) Charlie Batten +44 (0) 207 597 5184

 

Brunswick: Kate Holgate +44 (0) 207 404 5959

Jayne Rosefield +44 (0) 207 404 5959

 

 

A copy of this announcement will be available at www.ch2m.com

 

Notes for Editors

 

Headquartered near Denver, Colorado, employee-owned CH2M HILL is a global leader in consulting, design, design-build, operations and program management for government, industrial, and commercial customers. The firm's work is concentrated in the areas of water, transport, environmental services, energy, natural resources, and facilities. CH2M HILL has over 23,500 employees and annual revenue of approximately US$6.4 billion.

 

Disclosure requirements of the Takeover Code (the "Code")

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any paper offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any paper offeror is first identified.

 

An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any paper offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a paper offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any paper offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4). Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGZVVRRGGZG
Date   Source Headline
3rd Apr 20247:00 amRNSFY24 Trading Update
4th Jan 20247:00 amRNSContract Wins
22nd Nov 20237:00 amRNSInterim Results
21st Nov 202311:18 amRNSChange of Nominated Adviser and Broker
20th Nov 20231:19 pmRNSBoard Update
3rd Nov 202310:12 amRNSNotice of Results and Board Appointment
10th Oct 20237:00 amRNSInterim CFO Appointment
5th Sep 20237:00 amRNSFinal Results
25th Aug 20237:00 amRNSUpdate re FY23 Results and Trading Update
8th Jun 20237:00 amRNSTrading Update
5th May 20232:33 pmRNSHolding(s) in Company
18th Apr 20238:58 amRNSDirector/PDMR Shareholding
17th Apr 202312:51 pmRNSDirector/PDMR Shareholding
6th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
31st Mar 20239:05 amRNSSecond Price Monitoring Extn
31st Mar 20239:00 amRNSPrice Monitoring Extension
31st Mar 20237:00 amRNSTrading Update
8th Mar 20233:30 pmRNSHolding(s) in Company
28th Feb 20231:26 pmRNSExercise of Options
8th Dec 20222:34 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
1st Dec 20222:40 pmRNSDirector/PDMR Shareholding
29th Nov 20222:05 pmRNSSecond Price Monitoring Extn
29th Nov 20222:00 pmRNSPrice Monitoring Extension
29th Nov 20227:00 amRNSResults for the six months ended 30 September 2022
23rd Nov 20227:00 amRNSAdviser Update
17th Nov 20227:00 amRNSNotice of Results and Presentation to Investors
7th Oct 20228:32 amRNSHolding(s) in Company
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
21st Sep 20227:00 amRNSResult of AGM
5th Sep 202210:00 amRNSNotice of AGM
1st Sep 20227:00 amRNSContract Renewal
25th Aug 20227:00 amRNSPosting of Annual Report
23rd Aug 20222:43 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSFinal Results
22nd Jul 20227:00 amRNSNotice of Results and Presentation to Investors
6th Jun 20224:41 pmRNSSecond Price Monitoring Extn
6th Jun 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSYear End Trading Update
13th Apr 20227:00 amRNSContract Win
24th Mar 20227:00 amRNSContract Win
22nd Mar 20224:37 pmRNSExercise of options
17th Mar 20227:00 amRNSContract Win
3rd Mar 20224:26 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSGrant of Options and Director/PDMR Dealing
27th Jan 20227:00 amRNSContract Renewals
11th Jan 20227:00 amRNSContract Win
14th Dec 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.